Pantec raises CHF20 million for IVF trials testing PLEASE delivery system

With CHF20 million (£12.4 million) under its belt from two new financings, Liechtenstein-based Pantec Biosolutions is gearing up for two Phase II clinical trials with hormone-based IVF therapies, to be delivered using transdermal patches in conjunction with the company's PLEASE (Painless Laser EpidermAl System) technology.